ClassID:

92846

C07C235/56 - CPC Classification

Classification description:

Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring

Recent Application in this class:
#1
20250304528
2025-10-02

OLIGO-BENZAMIDE ANALOGS AND THEIR USE IN CANCER TREATMENT

#2
20250263383
2025-08-21

NOVEL INHIBITORS OF GUANOSINE MONOPHOSPHATE SYNTHETASE AS THERAPEUTIC AGENTS

#3
20250100960
2025-03-27

NAPHTHALENE AND QUINOLINE ANALOGS AS RXFP1 AGONISTS

#4
20240366540
2024-11-07

MITOFUSIN INHIBITORS AND USES THEREOF

#5
20240360075
2024-10-31

N-SUBSTITUTED C6 CYCLYL CARBOXAMIDE COMPOUNDS AND USES THEREOF

#6
20240067600
2024-02-29

SMALL MOLECULE INHIBITORS OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (mtPTP)

#7
20230112489
2023-04-13

COMPOSITIONS AND METHODS OF MAKING EXPANDED HEMATOPOIETIC STEM CELLS USING DERIVATIVES OF FLUORENE

#8
20220396547
2022-12-15

SMALL MOLECULE INHIBITORS OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (mtPTP)

#9
20220298155
2022-09-22

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING

#10
20220281815
2022-09-08

CYCLOPROPYL-AMIDE COMPOUNDS AS DUAL LSD1/HDAC INHIBITORS

#11
20220125748
2022-04-28

HISTONE ACETYLTRANSFERASE (HAT) REGULATORS AND USES THEREOF

#12
20220048866
2022-02-17

Inhibitors of guanosine monophosphate synthetase as therapeutic agents

#13
20220017454
2022-01-20

Oligo-benzamide analogs and their use in cancer treatment

#14
20210395210
2021-12-23

INHIBITION OF BACTERIAL CHAPERONIN SYSTEMS

#15
20210347752
2021-11-11

BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS

#16
20210317074
2021-10-14

HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF

#17
20210317068
2021-10-14

COMPOSITIONS AND METHODS FOR GLUCOSE TRANSPORT INHIBITION

#18
20210284663
2021-09-16

Inhibitors of androgen receptor signaling

#19
20210230176
2021-07-29

Hepatitis B antiviral agents

#20
20210214324
2021-07-15

Biphenyl derivative compound and use thereof

#21
20210078937
2021-03-18

Benzoannulene derivatives as antiviral agents

#22
20210053909
2021-02-25

Antimicrobial compound and use thereof

#23
20200377464
2020-12-03

Propanamine derivatives for treating pain and pain related conditions

#24
20200308163
2020-10-01

Compounds and compositions as modulators of TLR signaling

#25
20200308110
2020-10-01

Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors

#26
20200255371
2020-08-13

Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene

#27
20200199143
2020-06-25

Hepatitis B antiviral agents

#28
20200115325
2020-04-16

Histone acetyltransferase activators and uses thereof

#29
20200087248
2020-03-19

Fluoroallylamine Derivative And Use Thereof

#30
20190345094
2019-11-14

Compositions and methods for glucose transport inhibition

#31
20190177268
2019-06-13

Compound, composition, cured object, optically anisotropic body, and reflective film

#32
20190127509
2019-05-02

Liquid-crystal compound, thermally responsive material, and production method therefor

#33
20190084994
2019-03-21

Hepatitis B antiviral agents

#34
20180346406
2018-12-06

Compositions and methods for glucose transport inhibition

#35
20180319741
2018-11-08

Sulfonylaminobenzamide compounds as anthelmintics

#36
20180282264
2018-10-04

Small molecule inhibitors of the mitochondrial permeability transition pore (mtPTP)

#37
20180251472
2018-09-06

Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same

#38
20180244606
2018-08-30

Farnesoid X receptor agonists and uses thereof

#39
20180230087
2018-08-16

Oligo-benzamide compounds and their use

#40
20180201602
2018-07-19

Vicinal primary diamines associated with metal and/or free radical chelation motifs, and active against carbonyl and oxidative stress, and use thereof

#41
20180079712
2018-03-22

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

#42
20180072660
2018-03-15

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

#43
20180002298
2018-01-04

COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

#44
20170253609
2017-09-07

Hepatitis B antiviral agents

#45
20170231999
2017-08-17

IDO inhibitors

#46
20170022150
2017-01-26

Hepatitis B antiviral agents

#47
20160368937
2016-12-22

Phosphonium compound, preparation method thereof, epoxy resin composition including the same, and semiconductor device prepared by using the same

#48
20160304485
2016-10-20

Small molecule inhibitors of Mcl-1 and uses thereof

#49
20160289171
2016-10-06

IDO inhibitors

#50
20160272584
2016-09-22

Biphenylamide derivative Hsp90 inhibitors

#51
20160257642
2016-09-08

Antimicrobial compounds

#52
20160200695
2016-07-14

Methods and compositions for selective and targeted cancer therapy

#53
20160199330
2016-07-14

Aniline derivatives, their preparation and their therapeutic application

#54
20160168132
2016-06-16

DI(HETERO)ARYLAMIDES AND SULFONAMIDES, METHODS FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF

#55
20160137585
2016-05-19

Compositions and methods for glucose transport inhibition

#56
20160130217
2016-05-12

Oligo-benzamide compounds and their use

#57
20160130215
2016-05-12

Cyclopropaneamine compound

#58
20160070030
2016-03-10

Optical film, circularly polarizing plate and organic electroluminescent display device

#59
20160039747
2016-02-11

Therapeutic aryl-amido-aryl compounds and their use

#60
20160031803
2016-02-04

Oligo-benzamide compounds and their use in treating cancers

#61
20160031797
2016-02-04

Estrogen receptor ligands and methods of use thereof

#62
20150376129
2015-12-31

Substituted benzamides with activity towards EP4 receptors

#63
20150266893
2015-09-24

Fused ring analogues of anti-fibrotic agents

#64
20150252043
2015-09-10

Hematopoietic growth factor mimetic small molecule compounds and their uses

#65
20150210717
2015-07-30

SPECIFIC INHIBITORS OF PROTEIN P21 AS THERAPEUTIC AGENTS

#66
20150191652
2015-07-09

Liquid crystal composition, method for manufacturing the same, and film

#67
20150105433
2015-04-16

TREATING VIRAL INFECTIONS HAVING VIRAL RNAs TRANSLATED BY A NON-IRES MEDIATED MECHANISM

#68
20150094406
2015-04-02

Thermoplastic polymer composition

#69
20150087758
2015-03-26

Thermoplastic polymer composition

#70
20150011794
2015-01-08

Ketoxime- and amide-functionalized nanomaterials

#71
20150011604
2015-01-08

Compounds for the treatment of neurodegenerative diseases

#72
20140350019
2014-11-27

Aniline derivatives, their preparation and their therapeutic application

#73
20140323568
2014-10-30

Oligo-benzamide compounds and their use in treating cancers

#74
20140228405
2014-08-14

Cyclopropaneamine compound

#75
20140220050
2014-08-07

Immunomodulator and anti-inflammatory compounds

#76
20140171468
2014-06-19

Estrogen receptor ligands and methods of use thereof

#77
20140057985
2014-02-27

ESTROGEN RECEPTOR LIGANDS AND METHODS OF USE THEREOF

#78
20140057946
2014-02-27

ESTROGEN RECEPTOR LIGANDS AND METHODS OF USE THEREOF

#79
20140038980
2014-02-06

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease

#80
20140018566
2014-01-16

PALLADIUM(II)-CATALYZED SELECTIVE FLUORINATION OF BENZOIC ACIDS AND DERIVATIVES

#81
20130338202
2013-12-19

Compounds for the treatment of neurodegenerative diseases

#82
20130338151
2013-12-19

Fused ring analogues of anti-fibrotic agents

#83
20130310351
2013-11-21

Treating long QT syndrome

#84
20130261185
2013-10-03

Benzamide Derivatives As EP4 Receptor Agonists

#85
20130253038
2013-09-26

Modified single-stranded polynucleotides

#86
20130245128
2013-09-19

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's

#87
20130231385
2013-09-05

OLIGO-BENZAMIDE COMPOUNDS AND THEIR USE

#88
20130224790
2013-08-29

Chalcone structure fluorescence dye for embryonic stem cell probe

#89
20130150442
2013-06-13

Oligo-benzamide compounds and their use in treating cancers

#90
20130150416
2013-06-13

Glutamate receptor modulators and therapeutic agents

#91
20130137775
2013-05-30

COMPOSITIONS AND METHODS FOR THE TREATMENT OF SYSTEMIC AA AMYLOID DISEASES

#92
20130121919
2013-05-16

Histone acetyltransferase activators and uses thereof

#93
20130072720
2013-03-21

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF OSTEOARTHRITIS

#94
20130011417
2013-01-10

Colchicine derivatives or pharmaceutically acceptable salts thereof, method for preparing said derivatives, and pharmaceutical composition comprising said derivatives

#95
20120322878
2012-12-20

Polycationic compounds and uses thereof

#96
20120295904
2012-11-22

Hematopoietic growth factor mimetic small molecule compounds and their uses

#97
20120289595
2012-11-15

Biarylamide derivative and compositions containing the derivative as an active ingredient

#98
20120270863
2012-10-25

FUSED RING ANALOGUES OF ANTI-FIBROTIC AGENTS

#99
20120225890
2012-09-06

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease

#100
20120196849
2012-08-02

COMPOUNDS AND COMPOSITIONS AS HEDGEHOG PATHWAY MODULATORS

#101
20120157539
2012-06-21

Nuclear receptor binding agents

#102
20120149737
2012-06-14

Therapeutic Aryl-Amido-Aryl Compounds and Their Use

#103
20120121536
2012-05-17

Compositions and methods for glucose transport inhibition

#104
20110294853
2011-12-01

Bis Aromatic Compounds for Use in the Treatment of Inflammation

#105
20110275603
2011-11-10

Immunomodulator and anti-inflammatory compounds

#106
20110237798
2011-09-29

Direct conversion of phenols into amides and esters of benzoic acid

#107
20110172239
2011-07-14

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease

#108
20110130387
2011-06-02

Sirtuin modulating compounds

#109
20110129419
2011-06-02

IN VIVO IMAGING AGENTS

#110
20110124664
2011-05-26

Polycationic compounds and uses thereof

#111
20110104055
2011-05-05

SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES

#112
20110086921
2011-04-14

Novel Polymorphic Forms of (4--2-Methylphenyl)Carbonyl]Amino}-3-Methylphenyl)Acetic Acid

#113
20110082209
2011-04-07

Novel Salts of (4--2-Methylphenyl)Carbonyl]Amino}-3-Methylphenyl)Acetic Acid

#114
20100317854
2010-12-16

NOVEL AMINODICARBOXYLIC ACID DERIVATIVES HAVING PHARMACEUTICAL PROPERTIES

#115
20100298344
2010-11-25

Polycationic compounds and uses thereof

#116
20100298330
2010-11-25

Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor

#117
20100286215
2010-11-11

BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION

#118
20100267773
2010-10-21

Estrogen receptor ligands and methods of use thereof

#119
20100249123
2010-09-30

NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE

#120
20100240677
2010-09-23

Compounds as PDE IV and TNF inhibitors

#121
20100179223
2010-07-15

Compounds, compositions, and methods for the treatment of synucleinopathies

#122
20100160327
2010-06-24

Modified malonate derivatives

#123
20100144884
2010-06-10

3-phenyl acrylic acid compound activators of type PPAR receptors and pharmaceutical/cosmetic compositions comprised thereof

#124
20100076078
2010-03-25

Insecticidal compounds

#125
20100048715
2010-02-25

Insecticidal compounds

#126
20100022650
2010-01-28

Benzamide derivatives as EPreceptor agonists

#127
20090324540
2009-12-31

Compounds and compositions for delivering active agents

#128
20090247637
2009-10-01

Anthranilic acid derivatives

#129
20090239919
2009-09-24

Glutamate receptor modulators and therapeutic agents

#130
20090239811
2009-09-24

Polycationic compounds and uses thereof

#131
20090215780
2009-08-27

Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity

#132
20090203906
2009-08-13

Aminodicarboxylic acid derivatives having pharmaceutical properties

#133
20090203666
2009-08-13

Compounds and compositions as hedgehog pathway modulators

#134
20090197965
2009-08-06

COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE

#135
20090143374
2009-06-04

Use of compounds and compositions for the treatment of amyloid diseases

#136
20090069432
2009-03-12

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease

#137
20090036420
2009-02-05

BENZAMIDE DERIVATIVES AND THEIR USE FOR TREATING CNS DISORDERS

#138
20080280989
2008-11-13

Hydroxybenzamide Derivatives, the Method For Preparing Thereof and the Cosmetic Composition Containing the Same

#139
20080188654
2008-08-07

Compounds for treatment of inflammation, diabetes and related disorders

#140
20080167377
2008-07-10

Novel compounds

#141
20080132706
2008-06-05

Compounds as PDE IV and TNF inhibitors

#142
20080132503
2008-06-05

Inhibitors of histone deacetylase

#143
20080108825
2008-05-08

Compounds for treatment of inflammation, diabetes and related disorders

#144
20080045546
2008-02-21

Tetradydro-Naphthalene And Urea Derivatives

#145
20080045483
2008-02-21

Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes

#146
20070276138
2007-11-29

Modulators of peroxisome proliferator activated receptors

#147
20070276034
2007-11-29

Compounds, compositions and methods for the treatment of synucleinopathies

#148
20070259961
2007-11-08

Compounds for treatment of inflammation, diabetes and related disorders

#149
20070238783
2007-10-11

β-Benzyloxyaspartate derivatives with amino group on benzene ring

#150
20070173498
2007-07-26

Melanin concentrating hormone antagonist

#151
20070088053
2007-04-19

Non-nucleoside reverse transcriptase inhibitors

#152
20070066623
2007-03-22

Entry inhibitors of the HIV virus

#153
20070037810
2007-02-15

Sirtuin modulating compounds

#154
20070037809
2007-02-15

Sirtuin modulating compounds

#155
20070037785
2007-02-15

Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases

#156
20060281810
2006-12-14

Novel anthranilic acid derivatives

#157
20060247274
2006-11-02

Substituted amino acids as erythropoietin mimetics

#158
20060166859
2006-07-27

Compounds and compositions for delivering active agents

#159
20060094769
2006-05-04

Aminodicarboxylic acid derivatives having pharmaceutical properties

#160
20060084809
2006-04-20

Compounds as PDE IV and TNF-inhibitors

#161
20060058298
2006-03-16

Inhibitors of histone deacetylase

#162
20060041024
2006-02-23

Polycationic compounds and uses thereof

#163
20060025594
2006-02-02

Small molecule entry inhibitors

#164
20060020003
2006-01-26

Biphenyloxy-acids

#165
20050288282
2005-12-29

Inhibitors of histone deacetylase

#166
20050187297
2005-08-25

Compounds, methods for their preparation and use thereof

#167
20050187246
2005-08-25

Cell proliferation inhibitors

#168
20050186176
2005-08-25

Compounds and compositions for delivering active agents

#169
20050182134
2005-08-18

Compounds and compositions for treating dysproliferative diseases, and methods of use thereof

#170
20050165114
2005-07-28

Benzene derivatives and pharmaceutical use thereof

#171
20050113450
2005-05-26

Antibacterial agents

#172
20050080024
2005-04-14

Nitric oxide donating derivatives for the treatment of cardiovascular disorders

#173
20050080021
2005-04-14

Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders

#174
20050020684
2005-01-27

Modulators of peroxisome proliferator activated receptors

#175
17730885
2022-10-25

Arylacetamides as AMP-activated protein kinase inhibitors and their use for treatment of breast cancer